Devices & Diagnostics Lucier makes first NuVasive acquisition: Buys Ellipse for $380M By Meghana Keshavan
Top Story Morning Read: Abbott pays $225M for heart valve replacement developer Tendyne, NuVasive coughs up $13.5M for false Medicare claim allegations By Nicole Oran
Devices & Diagnostics Spinal devices maker NuVasive’s chickens come home to roost By Arundhati Parmar
Artificial Intelligence, Devices & Diagnostics With AI, 3D imaging and a robot, Medtronic Spine aims to leave competitors bent out of shape By Arundhati Parmar
Devices & Diagnostics With $1.6B Mazor Robotics buy, Medtronic Spine hits reset button By Arundhati Parmar
Startups, BioPharma Edico Genome raises $22M to accelerate adoption of genomic analysis platform By Josh Baxt
Devices & Diagnostics 4 medical device M&A deals I’d like to see, with an eye to Abbott-St. Jude’s Medical By Varun Saxena
Daily Is Mark Cuban really healthcare clueless? Johns Hopkins stares down $1B lawsuit (Morning Read) By Nicole Oran
Daily Medical device patent law: Changes, subtleties and tricks-of-the-trade secrets By Meghana Keshavan
Devices & Diagnostics Sales reps not included: On e-commerce site, device firms discount routinely used implants By
Devices & Diagnostics U.S. implantable medical devices market will grow 8 percent to $73.9 billion by 2018 By Arundhati Parmar
Devices & Diagnostics Global spine surgery devices market to grow to $14.8 billion in five years By Arundhati Parmar
Devices & Diagnostics How do Wall Street analysts expect the Supreme Court to rule on Obamacare? By Arundhati Parmar
